INCREASED CYCLIC-AMP LEVELS ENHANCE IL-1-ALPHA AND IL-1-BETA MESSENGER-RNA EXPRESSION AND PROTEIN-PRODUCTION IN HUMAN MYELOMONOCYTIC CELL-LINES AND MONOCYTES

被引:45
作者
SUNG, SSJ
WALTERS, JA
机构
[1] VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT MICROBIOL & IMMUNOL, RICHMOND, VA 23298 USA
[2] VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, MASSEY CANC CTR, RICHMOND, VA 23298 USA
关键词
PROSTAGLANDINS; FORSKOLIN; CHOLERA TOXIN; TRANSCRIPTION RATE; MESSENGER RNA STABILITY;
D O I
10.1172/JCI115515
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The effects of increasing intracellular cAMP levels on IL-1-alpha and IL-1-beta mRNA expression and IL-1 production in human monocytes and nonlymphoid hematopoietic cell lines were examined. Peripheral monocytes and myelomonocytic cell lines could be stimulated by LPS or phorbol myristate acetate (PMA) to express IL-1 mRNA. Dibutyryl cAMP, 8-bromo-cAMP, forskolin, cholera toxin, PGE1, and PGE2 synergized with PMA or LPS to increase the accumulation in cell lines of IL-1-alpha mRNA by up to 50-fold and that of IL-1-beta mRNA by 10- to 20-fold compared to LPS or PMA alone. This increase in IL-1-alpha and IL-1-beta mRNA accumulation was more modest in monocytes. The synergistic stimulation was due to enhanced IL-1 gene transcription rate rather than increased IL-1 mRNA stability. Despite this marked increase in IL-1 mRNA accumulation, IL-1 protein synthesis in these cells was increased by only twofold. Thus, IL-1 synthesis in monocytes and myelomonocytic cell lines is under stringent translational control.
引用
收藏
页码:1915 / 1923
页数:9
相关论文
共 38 条
[1]   NORTHERN BLOT NORMALIZATION WITH A 28S RIBOSOMAL-RNA OLIGONUCLEOTIDE PROBE [J].
BARBU, V ;
DAUTRY, F .
NUCLEIC ACIDS RESEARCH, 1989, 17 (17) :7115-7115
[2]  
BENSIMON C, 1989, J IMMUNOL, V143, P1168
[3]  
BEUSCHER HU, 1990, J IMMUNOL, V144, P2179
[4]  
BRANDWEIN SR, 1986, J BIOL CHEM, V261, P8624
[5]   IDENTIFICATION OF A COMMON NUCLEOTIDE-SEQUENCE IN THE 3'-UNTRANSLATED REGION OF MESSENGER-RNA MOLECULES SPECIFYING INFLAMMATORY MEDIATORS [J].
CAPUT, D ;
BEUTLER, B ;
HARTOG, K ;
THAYER, R ;
BROWNSHIMER, S ;
CERAMI, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) :1670-1674
[6]  
COLEMAN DL, 1989, J IMMUNOL, V143, P4134
[7]  
DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335
[8]  
DINARELLO CA, 1987, J IMMUNOL, V139, P1902
[9]  
DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI [10.1016/s0065-2776(08)60642-2, 10.1016/S0065-2776(08)60642-2, DOI 10.1016/S0065-2776(08)60642-2]
[10]   PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION FROM COMPLEMENTARY-DNA OF A HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
EISENBERG, SP ;
EVANS, RJ ;
AREND, WP ;
VERDERBER, E ;
BREWER, MT ;
HANNUM, CH ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :341-346